Cost-effectiveness of Hepatitis C Virus Treatment Models for People Who Inject Drugs in Opioid Agonist Treatment Programs

類似資料

• Rationale, design, and methodology of a trial evaluating three models of care for HCV treatment among injection drug users on opioid agonist therapy
  著者:: Akiyama, Matthew J., 等
  出版事項: (2018)
• Factors and HCV treatment outcomes associated with smoking among people who inject drugs on opioid agonist treatment: secondary analysis of the PREVAIL randomized clinical trial
  著者:: Pericot-Valverde, Irene, 等
  出版事項: (2020)
• Intensive Models of Hepatitis C Care for People Who Inject Drugs Receiving Opioid Agonist Therapy: A Randomized Controlled Trial
  著者:: Akiyama, Matthew J., 等
  出版事項: (2019)
• Declines in Depressive Symptoms Among People who Inject Drugs Treated With Direct-Acting Antivirals While on Opioid Agonist Therapy
  著者:: Pericot-Valverde, Irene, 等
  出版事項: (2020)
• Low Hepatitis C Reinfection Following Direct-acting Antiviral Therapy Among People Who Inject Drugs on Opioid Agonist Therapy
  著者:: Akiyama, Matthew J, 等
  出版事項: (2020)